FI42565C - Menetelmä terapeuttisesti vaikuttavien 2-(2',4',6'-trimetyylibentsyyli)-1,3-diatsasyklopenteeni-(2)valmistamiseksi - Google Patents

Menetelmä terapeuttisesti vaikuttavien 2-(2',4',6'-trimetyylibentsyyli)-1,3-diatsasyklopenteeni-(2)valmistamiseksi

Info

Publication number
FI42565C
FI42565C FI622150A FI215062A FI42565C FI 42565 C FI42565 C FI 42565C FI 622150 A FI622150 A FI 622150A FI 215062 A FI215062 A FI 215062A FI 42565 C FI42565 C FI 42565C
Authority
FI
Finland
Prior art keywords
diazacyclopentene
trimethylbenzyl
preparation
therapeutically active
therapeutically
Prior art date
Application number
FI622150A
Other languages
English (en)
Other versions
FI42565B (fi
Inventor
Karl Zeile
Karl-Heinz Hauptmann
Helmut Staehle
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Application granted granted Critical
Publication of FI42565B publication Critical patent/FI42565B/fi
Publication of FI42565C publication Critical patent/FI42565C/fi

Links

Classifications

    • H—ELECTRICITY
    • H03—ELECTRONIC CIRCUITRY
    • H03G—CONTROL OF AMPLIFICATION
    • H03G1/00—Details of arrangements for controlling amplification
    • H03G1/0005—Circuits characterised by the type of controlling devices operated by a controlling current or voltage signal
    • H03G1/0017—Circuits characterised by the type of controlling devices operated by a controlling current or voltage signal the device being at least one of the amplifying solid-state elements
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q9/00—Preparations for removing hair or for aiding hair removal
    • A61Q9/02—Shaving preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI622150A 1961-11-30 1962-11-29 Menetelmä terapeuttisesti vaikuttavien 2-(2',4',6'-trimetyylibentsyyli)-1,3-diatsasyklopenteeni-(2)valmistamiseksi FI42565C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB64998A DE1154119B (de) 1961-11-30 1961-11-30 Verfahren zur Herstellung von 2-(2', 4', 6'-Trimethylbenzyl)-1, 3-diazacyclopenten-(2) und seinen Salzen

Publications (2)

Publication Number Publication Date
FI42565B FI42565B (fi) 1970-06-01
FI42565C true FI42565C (fi) 1970-09-14

Family

ID=6974599

Family Applications (1)

Application Number Title Priority Date Filing Date
FI622150A FI42565C (fi) 1961-11-30 1962-11-29 Menetelmä terapeuttisesti vaikuttavien 2-(2',4',6'-trimetyylibentsyyli)-1,3-diatsasyklopenteeni-(2)valmistamiseksi

Country Status (8)

Country Link
US (1) US3300511A (fi)
CH (1) CH418340A (fi)
DE (1) DE1154119B (fi)
FI (1) FI42565C (fi)
FR (1) FR1506256A (fi)
GB (1) GB965621A (fi)
NL (1) NL286080A (fi)
SE (1) SE219203C1 (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2008089B (en) * 1977-08-26 1982-06-09 Wellcome Found Imidazole derivatives and salts thereof their synthesis and intermediates and pharmaceutical formulations
EP0086428B1 (en) * 1979-08-23 1987-07-29 Beecham Group Plc Antidiarrhoea veterinary composition, its production and oral doser containing it
US5969137A (en) * 1996-09-19 1999-10-19 Virginia Commonwealth University Benzylamidine derivatives with serotonin receptor binding activity
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US20050026924A1 (en) * 2000-07-14 2005-02-03 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
WO2002005853A2 (en) * 2000-07-14 2002-01-24 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US20040214829A1 (en) * 2000-07-14 2004-10-28 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
HU230383B1 (hu) * 2000-07-14 2016-03-29 Allergan, Inc Oldékonyságfokozó komponens használata brimodinin-tartarátot tartalmazó vizes készítményekben

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2868802A (en) * 1959-01-13 Nxchj
US2161938A (en) * 1934-07-31 1939-06-13 Soc Of Chemical Ind Imidazolines

Also Published As

Publication number Publication date
SE219203C1 (sv) 1968-02-27
CH418340A (de) 1966-08-15
FR1506256A (fr) 1967-12-22
DE1154119B (de) 1963-09-12
GB965621A (en) 1964-08-06
FI42565B (fi) 1970-06-01
US3300511A (en) 1967-01-24
NL286080A (nl) 1965-02-10

Similar Documents

Publication Publication Date Title
FI42564C (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia 2-aryyliamino-1,3-diatsasykloalkeeneja
BE612901A (fr) Procédé de préparation d'orthoalcoylphénols
FI42565C (fi) Menetelmä terapeuttisesti vaikuttavien 2-(2',4',6'-trimetyylibentsyyli)-1,3-diatsasyklopenteeni-(2)valmistamiseksi
FR1319478A (fr) Procédé de préparation d'aminoquinones mono-substituées
FI46507C (fi) Menetelmä uuden terapeuttisesti käytettävän 1-metyyli-N-karbobentsoksi dihydrolysergamiinin valmistamiseksi.
SE218697C1 (sv) Förfarande för framställning av 7-pyrazolyl-(1')-3-fenyl-kumarin
BE617370A (fr) Procédé de préparation du 2,5-di-[benzoxazolyl-(2')]-thiofène
FI43994C (fi) Menetelmä uusien terapeuttisesti vaikuttavien 1,2-diaryyli-4-alkyyli-3,5-diokso-pyratsolidiinien valmistamiseksi
FR93252E (fr) Procédé de préparation d'haloalcoyl-thiazols.
FI46621C (fi) Menetelmä terapeuttisesti vaikuttavien 5-fenyyli-3H-1,4-bentsodiatsepi inijohdannaisten valmistamiseksi.
DK104414C (da) Fremgangsmåde til fremstilling af bis-N-acetylhydrazino-N'-karbonyl-metyl)-disulfid.
BE617181A (fr) Procédé de production du 4-(2',6',6'-triméthylcyclohexène-(1')-yl)-2-méthylbutène-(3)-al-(1)
FR1287250A (fr) Procédé de préparation de 4, 4'-dihydroxydiarylalcanes purs
DK111819B (da) Fremgangsmåde til fremstilling af acetonider af 4-(2'-carbo-α-glyceryloxyphenylamino)-chlorquinoliner.
FR1497451A (fr) Procédé de préparation des nu4nu4'-alkyles-1, 1'-alkyles-bis
CH407981A (it) Procedimento per la preparazione d'isoprene
FR1321198A (fr) Procédé de préparation du 2,5-di-[benzoxazolyl-(2')]-thiofène
FR1302193A (fr) Procédé de préparation de 1.3-dialkyl-cyclobuténolones
DK105204C (da) Fremgangsmåde til fremstilling af terapeutisk verkende salte af kinolinforbindelser.
GR22873B (el) Μεθοδος δια την παρασκευην θεραπευτικως ενεργων ενωσεων.
FR1318489A (fr) Procédé de préparation d'hydroxy-aldéhydes
FI40012C (fi) Menetelmä terapeuttisesti aktiivisten bentsokinolitsiini-johdannaisten valmistamiseksi
BE623148A (fr) Procédé de préparation d'haloalcoylthiazols.
FR1311541A (fr) Procédé de préparation de nouvelles trialkoxy-3, 4, 5 cinnamides
FR1324134A (fr) Procédé de préparation de 2,5-hexadiénoate de méthyle